Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

L. Moreno; M. Casanova; J.C. Chisholm; P. Berlanga; P.B. Chastagner; S. Baruchel; L. Amoroso; S.G. Melcón; N.U. Gerber; G. Bisogno; F. Fagioli; B. Geoerger; J.L. Glade Bender; I. Aerts; C. Bergeron; P. Hingorani; I. Elias; M. Simcock; S. Ferrara; Y. Le Bruchec; R. Slepetis; N. Chen; G. Vassal

doi:10.1016/j.ejca.2018.05.002

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

L. Moreno, M. Casanova, J.C. Chisholm, P. Berlanga, P.B. Chastagner, S. Baruchel, L. Amoroso, S.G. Melcón, N.U. Gerber, G. Bisogno, F. Fagioli, B. Geoerger, J.L. Glade Bender, I. Aerts, C. Bergeron, P. Hingorani, I. Elias, M. Simcock, S. Ferrara, Y. Le BruchecR. Slepetis, N. Chen, G. Vassal

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	27-34
Number of pages	8
Journal	European journal of cancer
Volume	100
DOIs	https://doi.org/10.1016/j.ejca.2018.05.002
Publication status	Published - 2018

Access to Document

10.1016/j.ejca.2018.05.002

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048796300&doi=10.1016%2fj.ejca.2018.05.002&partnerID=40&md5=6968c27d5ded3c347924637900b28395

Cite this

Moreno, L., Casanova, M., Chisholm, J. C., Berlanga, P., Chastagner, P. B., Baruchel, S., Amoroso, L., Melcón, S. G., Gerber, N. U., Bisogno, G., Fagioli, F., Geoerger, B., Glade Bender, J. L., Aerts, I., Bergeron, C., Hingorani, P., Elias, I., Simcock, M., Ferrara, S., ... Vassal, G. (2018). Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. European journal of cancer, 100, 27-34. https://doi.org/10.1016/j.ejca.2018.05.002

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. / Moreno, L.; Casanova, M.; Chisholm, J.C.; Berlanga, P.; Chastagner, P.B.; Baruchel, S.; Amoroso, L.; Melcón, S.G.; Gerber, N.U.; Bisogno, G.; Fagioli, F.; Geoerger, B.; Glade Bender, J.L.; Aerts, I.; Bergeron, C.; Hingorani, P.; Elias, I.; Simcock, M.; Ferrara, S.; Le Bruchec, Y.; Slepetis, R.; Chen, N.; Vassal, G.

In: European journal of cancer, Vol. 100, 2018, p. 27-34.

Research output: Contribution to journal › Article

Moreno, L, Casanova, M, Chisholm, JC, Berlanga, P, Chastagner, PB, Baruchel, S, Amoroso, L, Melcón, SG, Gerber, NU, Bisogno, G, Fagioli, F, Geoerger, B, Glade Bender, JL, Aerts, I, Bergeron, C, Hingorani, P, Elias, I, Simcock, M, Ferrara, S, Le Bruchec, Y, Slepetis, R, Chen, N & Vassal, G 2018, 'Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer', European journal of cancer, vol. 100, pp. 27-34. https://doi.org/10.1016/j.ejca.2018.05.002

Moreno, L. ; Casanova, M. ; Chisholm, J.C. ; Berlanga, P. ; Chastagner, P.B. ; Baruchel, S. ; Amoroso, L. ; Melcón, S.G. ; Gerber, N.U. ; Bisogno, G. ; Fagioli, F. ; Geoerger, B. ; Glade Bender, J.L. ; Aerts, I. ; Bergeron, C. ; Hingorani, P. ; Elias, I. ; Simcock, M. ; Ferrara, S. ; Le Bruchec, Y. ; Slepetis, R. ; Chen, N. ; Vassal, G. / Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer. In: European journal of cancer. 2018 ; Vol. 100. pp. 27-34.

@article{e313368751594e5ab3001f6266049dc8,

title = "Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer",

author = "L. Moreno and M. Casanova and J.C. Chisholm and P. Berlanga and P.B. Chastagner and S. Baruchel and L. Amoroso and S.G. Melc{\'o}n and N.U. Gerber and G. Bisogno and F. Fagioli and B. Geoerger and {Glade Bender}, J.L. and I. Aerts and C. Bergeron and P. Hingorani and I. Elias and M. Simcock and S. Ferrara and {Le Bruchec}, Y. and R. Slepetis and N. Chen and G. Vassal",

note = "Cited By :1 Export Date: 4 February 2019",

year = "2018",

doi = "10.1016/j.ejca.2018.05.002",

language = "English",

volume = "100",

pages = "27--34",

journal = "European Journal of Cancer",

issn = "0014-2964",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

AU - Moreno, L.

AU - Casanova, M.

AU - Chisholm, J.C.

AU - Berlanga, P.

AU - Chastagner, P.B.

AU - Baruchel, S.

AU - Amoroso, L.

AU - Melcón, S.G.

AU - Gerber, N.U.

AU - Bisogno, G.

AU - Fagioli, F.

AU - Geoerger, B.

AU - Glade Bender, J.L.

AU - Aerts, I.

AU - Bergeron, C.

AU - Hingorani, P.

AU - Elias, I.

AU - Simcock, M.

AU - Ferrara, S.

AU - Le Bruchec, Y.

AU - Slepetis, R.

AU - Chen, N.

AU - Vassal, G.

N1 - Cited By :1 Export Date: 4 February 2019

PY - 2018

Y1 - 2018

U2 - 10.1016/j.ejca.2018.05.002

DO - 10.1016/j.ejca.2018.05.002

M3 - Article

VL - 100

SP - 27

EP - 34

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0014-2964

ER -